•
Jun 30, 2023

Oscar Health Q2 2023 Earnings Report

Oscar Health's financial performance demonstrated pricing discipline, renewed operational focus, and solid execution.

Key Takeaways

Oscar Health, Inc. reported strong financial results for the second quarter ended June 30, 2023. Premiums earned increased by 48% year-over-year, and the net loss improved by $96.7 million year-over-year. The company is reaffirming its full year 2023 outlook.

Direct and Assumed Policy Premiums of $1.6 billion, a 3% decrease YoY

Premiums earned of $1.5 billion, a 48% increase YoY

Medical Loss Ratio of 79.9%, a 230 bps improvement YoY

Net loss of ($15.4) million, an improvement of $96.7 million YoY

Total Revenue
$1.52B
Previous year: $1.02B
+49.6%
EPS
-$0.07
Previous year: -$0.53
-86.8%
Medical Loss Ratio
79.9%
Previous year: 82.2%
-2.8%
Gross Profit
$1.52B
Previous year: $1.06B
+43.8%
Cash and Equivalents
$2.32B
Previous year: $2.36B
-1.7%
Total Assets
$4.56B
Previous year: $4.75B
-3.9%

Oscar Health

Oscar Health

Forward Guidance

Oscar is reaffirming its full year 2023 outlook across all metrics.